Cargando…

Oncogenic KRAS activates an embryonic stem cell-like program in human colon cancer initiation

Colorectal cancer is the third most frequently diagnosed cancer worldwide. Prevention of colorectal cancer initiation represents the most effective overall strategy to reduce its associated morbidity and mortality. Activating KRAS mutation (KRAS(mut)) is the most prevalent oncogenic driver in colore...

Descripción completa

Detalles Bibliográficos
Autores principales:	Le Rolle, Anne-France, Chiu, Thang K., Zeng, Zhaoshi, Shia, Jinru, Weiser, Martin R., Paty, Philip B., Chiu, Vi K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Priority Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823026/ https://www.ncbi.nlm.nih.gov/pubmed/26744320 http://dx.doi.org/10.18632/oncotarget.6818

Ejemplares similares

The prognostic significance of CXCL1 hypersecretion by human colorectal cancer epithelia and myofibroblasts
por: le Rolle, Anne-France, et al.
Publicado: (2015)

Cancer comes of age embryonically
por: Chiu, Vi K., et al.
Publicado: (2016)

Dual Inhibition of KRAS(G12D) and Pan-ERBB Is Synergistic in Pancreatic Ductal Adenocarcinoma
por: Gulay, Kevin Christian Montecillo, et al.
Publicado: (2023)

MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer cells
por: Kharbanda, Akriti, et al.
Publicado: (2014)

Acquisition of an oncogenic fusion protein serves as an initial driving mutation by inducing aneuploidy and overriding proliferative defects
por: Loupe, Jacob M., et al.
Publicado: (2016)

In vivo quantification and perturbation of Myc-Max interactions and the impact on oncogenic potential
por: Raffeiner, Philipp, et al.
Publicado: (2014)

Cis-acting elements in its 3′ UTR mediate post-transcriptional regulation of KRAS
por: Kim, Minlee, et al.
Publicado: (2016)

Troponin-I enhances and is required for oncogenic overgrowth
por: Casas-Tintó, Sergio, et al.
Publicado: (2016)

Comparison of SARS-CoV-2 RT-PCR on a high-throughput molecular diagnostic platform and the cobas SARS-CoV-2 test for the diagnostic of COVID-19 on various clinical samples
por: Opota, Onya, et al.
Publicado: (2020)

The impact of the MYB-NFIB fusion proto-oncogene in vivo
por: Mikse, Oliver R., et al.
Publicado: (2016)

Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors
por: Baldelli, Elisa, et al.
Publicado: (2015)

HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice
por: Esser, Alison K., et al.
Publicado: (2017)

A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cells
por: Ischenko, Irene, et al.
Publicado: (2015)

miR-155 is positively regulated by CBX7 in mouse embryonic fibroblasts and colon carcinomas, and targets the KRAS oncogene
por: Forzati, Floriana, et al.
Publicado: (2017)

Oncogenic Kras Initiates Leukemia in Hematopoietic Stem Cells
por: Sabnis, Amit J, et al.
Publicado: (2009)

Metabolic reprogramming of the premalignant colonic mucosa is an early event in carcinogenesis
por: Cruz, Mart Dela, et al.
Publicado: (2017)

Multi-focal control of mitochondrial gene expression by oncogenic MYC provides potential therapeutic targets in cancer
por: Oran, Amanda R., et al.
Publicado: (2016)

Liver X Receptor ligand cytotoxicity in colon cancer cells and not in normal colon epithelial cells depends on LXRβ subcellular localization
por: Courtaut, Flavie, et al.
Publicado: (2015)

Palbociclib resistance confers dependence on an FGFR-MAP kinase-mTOR-driven pathway in KRAS-mutant non-small cell lung cancer
por: Haines, Eric, et al.
Publicado: (2018)

MDM2 antagonists synergize broadly and robustly with compounds targeting fundamental oncogenic signaling pathways
por: Saiki, Anne Y., et al.
Publicado: (2014)

BIM mediates oncogene inactivation-induced apoptosis in multiple transgenic mouse models of acute lymphoblastic leukemia
por: Li, Yulin, et al.
Publicado: (2016)

A novel mechanism of regulation of the oncogenic transcription factor GLI3 by toll-like receptor signaling
por: Matissek, Stephan J., et al.
Publicado: (2022)

CPI-17 drives oncogenic Ras signaling in human melanomas via Ezrin-Radixin-Moesin family proteins
por: Riecken, Lars Björn, et al.
Publicado: (2016)

Oncogenic AKT1(E17K) mutation induces mammary hyperplasia but prevents HER2-driven tumorigenesis
por: Mancini, Maria L., et al.
Publicado: (2016)

Dynamics of telomeric repeat-containing RNA expression in early embryonic cleavage stages with regards to maternal age
por: Kordowitzki, Paweł, et al.
Publicado: (2020)

Overcoming resistance to single-agent therapy for oncogenic BRAF gene fusions via combinatorial targeting of MAPK and PI3K/mTOR signaling pathways
por: Jain, Payal, et al.
Publicado: (2017)

Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survival
por: Fink, Stephen P., et al.
Publicado: (2015)

Ecological consequences of temperature regulation: Why might the mountain pygmy possum Burramys parvus need to hibernate near underground streams?
por: Cooper, Chrisitne, et al.
Publicado: (2014)

Epigenetic suppression of EGFR signaling in G-CIMP+ glioblastomas
por: Li, Jie, et al.
Publicado: (2014)

Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds
por: Carrella, Diego, et al.
Publicado: (2016)

β-catenin activation drives thymoma initiation and progression in mice
por: Liang, Chih-Chia, et al.
Publicado: (2015)

The heat is on: Molecular mechanisms of drug-induced hyperthermia
por: Dao, Christine K, et al.
Publicado: (2014)

Asymptomatic SARS-CoV-2 infection: is it all about being refractile to innate immune sensing of viral spare-parts?—Clues from exotic animal reservoirs
por: Shankar, Esaki M, et al.
Publicado: (2020)

Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancer
por: Jimenez-Rodriguez, Rosa M., et al.
Publicado: (2020)

Spatially- and temporally-controlled postnatal p53 knockdown cooperates with embryonic Schwann cell precursor Nf1 gene loss to promote malignant peripheral nerve sheath tumor formation
por: Hirbe, Angela C., et al.
Publicado: (2016)

Oncogenic mutation or overexpression of oncogenic KRAS or BRAF is not sufficient to confer oncogene addiction
por: Ito, Reina E., et al.
Publicado: (2021)

Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumors
por: Gupta, Jalaj, et al.
Publicado: (2015)

Interleukin-4 and interleukin-13 increase NADPH oxidase 1-related proliferation of human colon cancer cells
por: Liu, Han, et al.
Publicado: (2017)

Acrometastasis as the Initial Presentation of a KRAS-Positive Colon Cancer
por: Gharwan, Helen, et al.
Publicado: (2012)

Oncogenic KRAS signalling in pancreatic cancer
por: Eser, S, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_m9kt70mu9qoqshcc7rgc2uegua